Associations Between Serum Bone Biomarkers in Early Breast Cancer and Development of Bone Metastasis: Results From the AZURE (BIG01/04) Trial

BACKGROUND: Adjuvant therapies can prevent/delay bone metastasis development in breast cancer. We investigated whether serum bone turnover markers in early disease have clinical utility in identifying patients with a high risk of developing bone metastasis. METHODS: Markers of bone formation (N-term...

Descripción completa

Detalles Bibliográficos
Autores principales: Brown, Janet, Rathbone, Emma, Hinsley, Samantha, Gregory, Walter, Gossiel, Fatma, Marshall, Helen, Burkinshaw, Roger, Shulver, Helen, Thandar, Hasina, Bertelli, Gianfilippo, Maccon, Keane, Bowman, Angela, Hanby, Andrew, Bell, Richard, Cameron, David, Coleman, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093369/
https://www.ncbi.nlm.nih.gov/pubmed/29425304
http://dx.doi.org/10.1093/jnci/djx280

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093369/
https://www.ncbi.nlm.nih.gov/pubmed/29425304
http://dx.doi.org/10.1093/jnci/djx280

Ejemplares similares